Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Pfizer (PFE), Bristol Myers Squibb (BMY)
- Julie catches up with participants of the big pharma-sponsored New York AIDS Walk.
- Videos 2008-05-21
Additional Resources
- Skilled, Available Workers Top Pharmaceutical Site Seekers' Wish List
- One of the biggest contributors to a move is work force -- not only skilled, but available workers. That is a big problem today, because the national unemployment rate is so low. Pharmaceutical companies tend to look at the talent, but it is definitely an employee's market out there. A...
- White papers 2003-01-01
- Par expands its partnership with Merck. (Roundup).(Par Pharmaceutical Inc., Merck KGaA)(Brief Article)
- Par Pharmaceutical Inc., a subsidiary of Pharmaceutical Resources Inc., has entered into an agreement to expand its product partnership with Merck KGaA. Par has licensed from Merck the exclusive rights to 11 generic pharmaceutical products under .. Par Pharmaceutical Inc., a subsidiary of Pharmaceutical...
- Research articles 2002-04-15
- NORTHEAST PHARMACEUTICAL GROUP SOLD ARM TO PARENT
- AsiaInfo Services 12-31-2007 Northeast Pharmaceutical Group Sold Arm to Parent SHENYANG, Dec 31, 2007 SinoCast via COMTEX -- Shenyang-based pharmaceutical company Northeast Pharmaceutical Group Co., Ltd. (SZSE: 000597) sold a 99% stake in its AsiaInfo Services 12-31-2007...
- Research articles 2007-12-31
- Dendrite Japan rolls out sales force effectiveness tools at four major Japanese pharmaceutical companies; More than 3,500 Sales Force Personnel at Teijin Ltd., Tsumura & Co., Ono Pharmaceutical and Dainippon Pharmaceutical Co., Ltd. begin using Dendri
- M2 PRESSWIRE-6 July 2001-DENDRITE: Dendrite Japan rolls out sales force effectiveness tools at four major Japanese pharmaceutical companies; More than 3,500 Sales Force Personnel at Teijin Ltd., Tsumura & Co., Ono Pharmaceutical and Dainippon Pharmaceutical Co., Ltd. begin using Dendrite's j-ForceWeb Product C1994-2001...
- Research articles 2001-07-06
- FAST 40: Generic drug niche grows for Cypress Pharmaceutical
- Cypress Pharmaceutical Inc., a specialty pharmaceutical company, based in Madison. After selling products for other pharmaceutical companies for years, Max Draughn took a leap of faith. With only one product to sell generic cough/cold relief medicine he established Cypress Pharmaceutical Inc., in Madison. Since that sultry July day in 1993,...
- Research articles 2005-11-28
- The management behind the molecules: pharmaceutical CEOs outline their key revenue drivers. (Focus 2003: Active Pharmaceutical Ingredients).
- Many concede that 2003 will be a transition year for the major pharmaceutical companies in terms of new drug development and product launches. That will put an even greater pressure on companies' mainstay products as pharmaceutical executives work Many concede that 2003 will...
- Research articles 2003-03-17
- William G. Dempsey. (Jobs and People).(named senior vice president of pharmaceutical operations for Abbott Laboratories' US pharmaceutical business)(Brief Article)
- William G. Dempsey has been named senior vice president of pharmaceutical operations for Abbott Laboratories' US pharmaceutical ... William G. Dempsey has been named senior vice president of pharmaceutical operations for Abbott Laboratories' US pharmaceutical business. Mr. Dempsey has spent more than 20...
- Research articles 2003-03-31
- Miami--Ivax (AMEX-IVX) shareholders approved the sale of the Miami-based pharmaceutical maker to Israel's Teva Pharmaceutical Industries. Ivax founder Philip Frost will stay on as vice chairman. The merger should be completed early this year.(BUSINESS BRI
- MIAMI -- Ivax (AMEX-IVX) shareholders approved the sale of the Miami-based pharmaceutical maker to Israel's Teva Pharmaceutical Industries. Ivax founder Philip Frost will stay on as vice chairman. The merger should be completed early this year. * Mia MIAMI -- Ivax (AMEX-IVX) shareholders approved the sale...
- Research articles 2006-01-01
- Dendrite Gives Shanghai SINE Medicine Company the Ability to Meet the Unique Needs of Chinese Pharmaceutical Market; Increased Penetration in Chinese Market Illustrates Growing Global Embrace of Dendrite Solutions
- BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ: DRTE), a leading provider of pharmaceutical industry solutions, today announced a comprehensive three-year agreement to provide SINE Pharmaceutical Company Co., Ltd, a subsidiary of Shanghai Pharmaceutical Group Co., Ltd SPGC and pioneer in China's growing pharmaceutical market, with components of Dendrite's Sales Solutions....
- Research articles 2006-06-02
- Teva Pharmaceutical corrects headline; headline should read Teva enters negotiation to acquire a European based pharmaceutical company
- --BUSINESS WIRE--In BW1006, (TEVA-PHARMACEUTICAL) Enters Negotiation, headline should read Teva Enters Negotiation To Acquire a European Based Pharmaceutical Company (sted multinational, European Based Pharmaceutical Company).CONTACT: Teva Pharmaceutical Industries Ltd.Dan SuesskindChief Financial Officer(011) 972-2-892-840orInvestor Relations: Donna N. SteinPress: Erika Brown (212) 850-5689Morgen Walke Associates, Inc.(212) 850-5600
- Research articles 1996-07-05
- Networking Your Way To A Pharmaceutical Sales Job
- Surfing the net for a pharmaceutical sales job is tiresome and looking at classified job ads can be tedious and well... boring. But what about business networking? No, it's not as tedious as it sounds. In fact, it can be fun and interesting because you get to meet lots of...
- White papers 2008-01-01
- Danish pharmaceutical company H Lundbeck A/S signs cooperation agreement with Japan's Takeda Pharmaceutical Company Limited
- NORDIC BUSINESS REPORT-5 September 2007-Danish pharmaceutical company H Lundbeck A/S signs cooperation agreement with Japan's Takeda Pharmaceutical Company LimitedC1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com Danish pharmaceutical company H Lundbeck A/S announced on Wednesday (5 September) a strategic alliance with Japan's Takeda Pharmaceutical Company Limited. The companies will cooperate in...
- Research articles 2007-09-05
- Securing the Pharmaceutical Supply Chain - The Authenticated RFID Platform
- Ensuring a safe and secure pharmaceutical supply chain is an important and challenging task. The need to build security into pharmaceutical products, packaging and supply chains has never been greater because of the increasing sophistication of well-funded counterfeiters. This paper describes how a matched component Authenticated RFID Platform delivers a...
- White papers 2005-06-01
- Prescriptions for the Smart & Lean Pharmaceutical Company
- This report is based on a research covering the viewpoints and needs of pharmaceutical customers and their evolving relationship with the pharmaceutical industry. It provides a unique snapshot of the customer perspective on healthcare, shedding light on what customers want from healthcare and pharmaceutical companies, and how they want to...
- White papers 2004-04-06
- FDA Regulations and Auditing Practices for Software Suppliers at a Pharmaceutical Manufacturer
- This paper investigates the software- supplier auditing practices in the pharmaceutical manufacturing environment by reviewing 17 quality audit reports performed between 1992 and 2003 by a major international pharmaceutical company. From this analysis three novel time frames of audit maturity eras are defined on the basis of government regulation enforcement...
- White papers 2004-08-23
- The Right Spice: Pharmaceutical Market Entry In India
- Poised on the cusp of an exciting period of growth, the Indian pharmaceutical market is big and getting bigger, driven by growing prosperity, a shift in disease patterns and governmental reforms that are unlocking new opportunities for MultiNational Companies MNCs. But this growth also has been accompanied by uncertainty around...
- White papers 2008-02-20
- Is Pharma M&A the Key to Strengthening the Pipeline?(Pharmaceutical industry mergers and acquisitions)(Statistical Data Included)
- Building critical mass to fund research and development is one of the most significant issues ongoing in the pharmaceutical industry. However, the critical question is whether pharmaceutical mergers and acquisitions really strengthen the drug pipel Building critical mass to fund research and development is...
- Research articles 2000-08-21
- Bayer changes tune on fate of pharma unit. (News).(Bayer AG drops insistance on majority control of pharmaceutical partnership)
- BAYER AG has lifted a major barrier to the merger of its pharmaceutical unit with another drugmaker by dropping its insistence on majority control of a pharmaceutical partnership. "A possible partnership must not be prevented by rigid in ...
- Research articles 2002-11-18
- Key pharmaceutical markets except growth through 2005.(IMS Health Inc. forecasts growth in Latin America pharmaceutical markets)(Brief Article)(Industry Overview)(Statistical Data Included)
- Sales in seven key Latin American pharmaceutical markets will grow at a compound average rate of 7.8 percent constant dollar for the five years through 2005, according to a new study released by IMS Health of Westport. Strong pharmaceutical sales Sales in...
- Research articles 2001-04-16
- << Previous
- page 1 of 1
- Next >>
